Ripretinib

CHEBI:CHEBI_751399

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2369403
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
dosage_form
POWDER
active_ingredient_strength
1 kg/kg
pharm_class_moa
Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]
pharm_class
Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]
nui
N0000020028
pharm_class_epc
Kinase Inhibitor [EPC]
marketing_start_date
20200224
package_marketing_start_date
24-FEB-20
labeler_name
Deciphera Pharmaceuticals, LLC
generic_name
Ripretinib
product_ndc
59116-5330
spl_id
a40f4421-88f9-0fe2-e053-2995a90a69b7
active_ingredient_name
RIPRETINIB
package_ndc
59116-5330-3
package_description
50 kg in 1 DRUM (59116-5330-3)
brand_name
QINLOCK
brand_name_base
QINLOCK
application_number
NDA213973
manufacturer_name
Deciphera Pharmaceuticals, LLC
unii
9XW757O13D
spl_set_id
9f18e462-03dd-4296-a02a-a0577e3ee78d
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class